Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Alliance District Lobby Days Planned for Mid-October. Please Participate Read More Analysis and Commentary STEVEN GROSSMAN 9/9/16 Analysis and Commentary STEVEN GROSSMAN 9/9/16 Omnibus, Minibus, or Any Type of Bus at All? Read More Advocacy at a Glance STEVEN GROSSMAN 9/9/16 Advocacy at a Glance STEVEN GROSSMAN 9/9/16 CDRH Director Shuren’s Presentation Well Received. Read More Analysis and Commentary STEVEN GROSSMAN 8/28/16 Analysis and Commentary STEVEN GROSSMAN 8/28/16 The Cost -- and the Importance -- of Public Attention Read More Advocacy at a Glance STEVEN GROSSMAN 8/28/16 Advocacy at a Glance STEVEN GROSSMAN 8/28/16 Congress Returns Soon; Unclear How Long It Will Stay Read More Analysis and Commentary STEVEN GROSSMAN 8/20/16 Analysis and Commentary STEVEN GROSSMAN 8/20/16 Exceptionalism in Predictably Challenging Times Read More Advocacy at a Glance STEVEN GROSSMAN 8/20/16 Advocacy at a Glance STEVEN GROSSMAN 8/20/16 Appropriations Status Unchanged Read More Analysis and Commentary STEVEN GROSSMAN 8/15/16 Analysis and Commentary STEVEN GROSSMAN 8/15/16 Management of Accountability to Varied Audiences Read More Advocacy at a Glance STEVEN GROSSMAN 8/15/16 Advocacy at a Glance STEVEN GROSSMAN 8/15/16 Key Congressional Decisions: CR or Omnibus; December or March Read More Analysis and Commentary STEVEN GROSSMAN 7/29/16 Analysis and Commentary STEVEN GROSSMAN 7/29/16 FDA Must Do More ... But How Much More for Less? Read More Advocacy at a Glance STEVEN GROSSMAN 7/29/16 Advocacy at a Glance STEVEN GROSSMAN 7/29/16 Status of Appropriations Read More Analysis and Commentary STEVEN GROSSMAN 7/22/16 Analysis and Commentary STEVEN GROSSMAN 7/22/16 No Taking Sides Here at the Alliance! Read More Advocacy at a Glance STEVEN GROSSMAN 7/22/16 Advocacy at a Glance STEVEN GROSSMAN 7/22/16 FDA Issues Strategic Plan for Food Safety and Veterinary Medicine Read More Analysis and Commentary STEVEN GROSSMAN 7/15/16 Analysis and Commentary STEVEN GROSSMAN 7/15/16 Coming Soon: A Future Year of Massive Change Read More Advocacy at a Glance STEVEN GROSSMAN 7/15/16 Advocacy at a Glance STEVEN GROSSMAN 7/15/16 Congress’ Summer Adjournment; Back in September Read More Analysis and Commentary STEVEN GROSSMAN 7/8/16 Analysis and Commentary STEVEN GROSSMAN 7/8/16 Little Good News is Bad News Read More Advocacy at a Glance STEVEN GROSSMAN 7/8/16 Advocacy at a Glance STEVEN GROSSMAN 7/8/16 One Week until Congress’ Summer Adjournment Read More Analysis and Commentary STEVEN GROSSMAN 6/25/16 Analysis and Commentary STEVEN GROSSMAN 6/25/16 Time to Face Up to the Future Read More Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Congressional Calendar Leaves Little Time for Legislating Read More Analysis and Commentary STEVEN GROSSMAN 6/17/16 Analysis and Commentary STEVEN GROSSMAN 6/17/16 Let's Praise FDA for What is Going Well! Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Alliance District Lobby Days Planned for Mid-October. Please Participate Read More
Analysis and Commentary STEVEN GROSSMAN 9/9/16 Analysis and Commentary STEVEN GROSSMAN 9/9/16 Omnibus, Minibus, or Any Type of Bus at All? Read More
Advocacy at a Glance STEVEN GROSSMAN 9/9/16 Advocacy at a Glance STEVEN GROSSMAN 9/9/16 CDRH Director Shuren’s Presentation Well Received. Read More
Analysis and Commentary STEVEN GROSSMAN 8/28/16 Analysis and Commentary STEVEN GROSSMAN 8/28/16 The Cost -- and the Importance -- of Public Attention Read More
Advocacy at a Glance STEVEN GROSSMAN 8/28/16 Advocacy at a Glance STEVEN GROSSMAN 8/28/16 Congress Returns Soon; Unclear How Long It Will Stay Read More
Analysis and Commentary STEVEN GROSSMAN 8/20/16 Analysis and Commentary STEVEN GROSSMAN 8/20/16 Exceptionalism in Predictably Challenging Times Read More
Advocacy at a Glance STEVEN GROSSMAN 8/20/16 Advocacy at a Glance STEVEN GROSSMAN 8/20/16 Appropriations Status Unchanged Read More
Analysis and Commentary STEVEN GROSSMAN 8/15/16 Analysis and Commentary STEVEN GROSSMAN 8/15/16 Management of Accountability to Varied Audiences Read More
Advocacy at a Glance STEVEN GROSSMAN 8/15/16 Advocacy at a Glance STEVEN GROSSMAN 8/15/16 Key Congressional Decisions: CR or Omnibus; December or March Read More
Analysis and Commentary STEVEN GROSSMAN 7/29/16 Analysis and Commentary STEVEN GROSSMAN 7/29/16 FDA Must Do More ... But How Much More for Less? Read More
Advocacy at a Glance STEVEN GROSSMAN 7/29/16 Advocacy at a Glance STEVEN GROSSMAN 7/29/16 Status of Appropriations Read More
Analysis and Commentary STEVEN GROSSMAN 7/22/16 Analysis and Commentary STEVEN GROSSMAN 7/22/16 No Taking Sides Here at the Alliance! Read More
Advocacy at a Glance STEVEN GROSSMAN 7/22/16 Advocacy at a Glance STEVEN GROSSMAN 7/22/16 FDA Issues Strategic Plan for Food Safety and Veterinary Medicine Read More
Analysis and Commentary STEVEN GROSSMAN 7/15/16 Analysis and Commentary STEVEN GROSSMAN 7/15/16 Coming Soon: A Future Year of Massive Change Read More
Advocacy at a Glance STEVEN GROSSMAN 7/15/16 Advocacy at a Glance STEVEN GROSSMAN 7/15/16 Congress’ Summer Adjournment; Back in September Read More
Analysis and Commentary STEVEN GROSSMAN 7/8/16 Analysis and Commentary STEVEN GROSSMAN 7/8/16 Little Good News is Bad News Read More
Advocacy at a Glance STEVEN GROSSMAN 7/8/16 Advocacy at a Glance STEVEN GROSSMAN 7/8/16 One Week until Congress’ Summer Adjournment Read More
Analysis and Commentary STEVEN GROSSMAN 6/25/16 Analysis and Commentary STEVEN GROSSMAN 6/25/16 Time to Face Up to the Future Read More
Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Congressional Calendar Leaves Little Time for Legislating Read More
Analysis and Commentary STEVEN GROSSMAN 6/17/16 Analysis and Commentary STEVEN GROSSMAN 6/17/16 Let's Praise FDA for What is Going Well! Read More
